Author(s): Nunes-Silva, C ; Vilares, AT ; Schweitzer, V ; Castanhinha, S ; Martins, A ; Lopes, MJ ; Ascoli-Bartoli, T ; Canelas, G ; Keir, HR ; Cunha, F ; Silva-Pinto, A ; Rebelo, S ; Cunha, RG ; Tavares, M
Date: 2022
Persistent ID: http://hdl.handle.net/10400.17/4291
Origin: Repositório do Centro Hospitalar de Lisboa Central, EPE
Subject(s): COVID-19; Respiratory viral infection; HDE PED
Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.
